Patent details
LUC50019 Product Name: Neratinib
Basic Information
- Publication number:
- LUC50019
- Type:
- SPC
- SPC Type:
- Medical
- Basic Patent Number:
- EP221697717
- Legal Status:
- Pending & Published
- Application number:
- LUC50019
- First applicant's nationality:
- Procedural language:
- French
Marketing Authorization
- Marketing Authorization Number:
- EU/1/18/1311
- Marketing Authorization Type:
- Marketing Authorization Date:
- 04/09/2018
- Marketing Authorization Status:
- Claimed
- Marketing Authorization Country:
- Luxembourg (LU)
Dates
- Filing date:
- 18/08/2025
- First Marketing Authorization date:
- 04/09/2018
- Grant date:
- Activation date:
- Publication date:
- 18/08/2025
- Lapsed date:
- Expiration date:
- Renunciation date:
- Revocation date:
- Annulment date:
- Basic SPC Expiration:
- 04/09/2033
- SPC Extension Expiration:
- 04/09/2033
- Rejection date:
- Withdrawal date:
Owner
- From:
- 18/08/2025
- Name:
- Wyeth LLC
- Address:
- 66 Hudson Boulevard East, New York, NY 10001-2192, United States (US)
Agent
- Name:
- OFFICE FREYLINGER S.A.
- From:
- 18/08/2025
- Address:
- Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
- To:
Publication
Bulletin
- Bulletin Heading:
- SPC1
- Bulletin edition number:
- 2025/10
- Publication date:
- 05/09/2025
- Description:
- Section C : Published requests for Supplementary Protection Certificates – I1 publication
| Filing date | Document type | Number of pages |
|---|---|---|
| 18/08/2025 | General Document | 1 |
| 18/08/2025 | Outgoing Correspondence | 2 |
| 18/08/2025 | General Document | 33 |
| 18/08/2025 | General Document | 3 |
| 18/08/2025 | General Document | 1 |
| 18/08/2025 | General Document | 13 |
| 18/08/2025 | Application Form | 5 |
| 18/08/2025 | Outgoing Correspondence | 1 |
| 18/08/2025 | Publication | 1 |
| 18/09/2025 | Outgoing Correspondence | 1 |